The higher serum S100A8/A9 levels in the NPSLE patients may indicate an ongoing SLE-related systemic inflammatory process, not completely controlled by immunosuppression, possibly contributing to neuropsychiatric symptoms. The gene discussed is S100A8; the disease is systemic lupus erythematosus.